Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Mouse ACE/CD143 Antibody, R&D Systems™

Goat Polyclonal Antibody has been used in 4 publications
Supplier: R&D Systems AF1513
This item is not returnable.
View return policy
Description
ACE/CD143 Polyclonal specifically detects ACE/CD143 in Mouse samples. It is validated for Western Blot, Simple Western, Flow Cytometry, Immunohistochemistry, Immunoprecipitation, CyTOF-ready.Specifications
ACE/CD143 | |
Polyclonal | |
Unconjugated | |
P09470 | |
ACE | |
Mouse myeloma cell line NS0-derived recombinant mouse ACE/CD143 Leu35-Gln1264 Accession # P09470 | |
100 μg | |
Primary | |
Detects mouse ACE in direct ELISAs and Western blots. In direct ELISAs, approximately 20% cross-reactivity with recombinant human ACE is observed. | |
Mouse | |
IgG |
Western Blot, Flow Cytometry, Immunohistochemistry, Immunoprecipitation, CyTOF | |
LYOPH | |
Western Blot 0.05 ug/mL, Simple Western 10 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, Immunohistochemistry 5-15 ug/mL, Immunoprecipitation 25 ug/mL, CyTOF-ready | |
ACE1angiotensin converting enzyme, somatic isoform, angiotensin I converting enzyme (peptidyl-dipeptidase A) 1, carboxycathepsin, CD143, CD143 antigen, DCP, DCP1, DCP1angiotensin-converting enzyme, dipeptidyl carboxypeptidase 1, Dipeptidyl carboxypeptidase I, EC 3.2.1.-, EC 3.4.15.1, Kininase II, MGC26566, MVCD3, peptidase P, testicular ECA | |
Goat | |
Affinity Purified | |
RUO | |
1636 | |
Reconstitute at 0.2 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction